VWF and medical procedure: In fact, ALX-0081, a nanobody against the A1 domain of VWF that blocks VWF binding to GPIbα, has recently been shown to prevent middle cerebral artery (MCA) thrombosis in guinea pigs and to induce reperfusion when given immediately after complete occlusion, without provoking intracerebral bleeding [89].